1. Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions
- Author
-
Sengupta, Rajarshi, Barone, Amy, Marasa, Jayne, Taylor, Sara, Jackson, Erin, Warrington, Nicole M, Rao, Shyam, Kim, Albert H, Leonard, Jeffrey R, Piwnica-Worms, David, and Rubin, Joshua B
- Subjects
Brain Cancer ,Rare Diseases ,Stem Cell Research - Nonembryonic - Human ,Stem Cell Research ,Cancer ,Neurosciences ,Brain Disorders ,Development of treatments and therapeutic interventions ,5.1 Pharmaceuticals ,Animals ,Brain Neoplasms ,Cell Communication ,Cell Line ,Tumor ,Cells ,Cultured ,Coculture Techniques ,Endothelial Cells ,Female ,Glioblastoma ,Humans ,Mice ,Nude ,Phytotherapy ,Plant Extracts ,Protamines ,Resveratrol ,Small Molecule Libraries ,Spirostans ,Stilbenes ,Survival Analysis ,Tumor Burden ,Tumor Cells ,Cultured ,Xenograft Model Antitumor Assays ,GBM ,Iridin ,co-culture ,high throughput screen ,perivascular niche ,Oncology and Carcinogenesis - Abstract
Tumor growth is not solely a consequence of autonomous tumor cell properties. Rather, tumor cells act upon and are acted upon by their microenvironment. It is tumor tissue biology that ultimately determines tumor growth. Thus, we developed a compound library screen for agents that could block essential tumor-promoting effects of the glioblastoma (GBM) perivascular stem cell niche (PVN). We modeled the PVN with three-dimensional primary cultures of human brain microvascular endothelial cells in Matrigel. We previously demonstrated stimulated growth of GBM cells in this PVN model and used this to assay PVN function. We screened the Microsource Spectrum Collection library for drugs that specifically blocked PVN function, without any direct effect on GBM cells themselves. Three candidate PVN-disrupting agents, Iridin, Tigogenin and Triacetylresveratrol (TAR), were identified and evaluated in secondary in vitro screens against a panel of primary GBM isolates as well as in two different in vivo intracranial models. Iridin and TAR significantly inhibited intracranial tumor growth and prolonged survival in these mouse models. Together these data identify Iridin and TAR as drugs with novel GBM tissue disrupting effects and validate the importance of preclinical screens designed to address tumor tissue function rather than the mechanisms of autonomous tumor cell growth.
- Published
- 2015